Recro Pharma Aktie

Watchlist REPH WKN A1XFAV ISIN US75629F1093

Was macht Recro Pharma?

Unternehmensprofil
Unternehmensprofil

Recro Pharma is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially in the post-operative setting. The company's lead product, an intranasal formulation of Dexmedetomidine, or Dex, has completed a Phase Ib placebo-controlled trial demonstrating pain relief. It was founded in 2007 and headquartered in Malvern, Pennsylvania.

Chart der Recro Pharma Aktie

Charttool öffnen